Drug intelligence / Profile preview

LumeniX

Development stage
Unknown
Lead developer
iX Biopharma
Modality
Peptides, Small Molecules
Administration
Sublingual
01

Overview

LumeniX is a sublingual nutraceutical supplement developed by Entity Health, the nutraceutical division of the Australian pharmaceutical company iX Biopharma. The product's primary active ingredient is glutathione, a potent antioxidant. LumeniX is formulated using the proprietary WaferiX sublingual wafer technology, which is designed to enhance the absorption and bioavailability of glutathione by allowing it to dissolve under the tongue and enter the bloodstream directly, bypassing first-pass metabolism in the digestive system. It is marketed as a skin brightening and anti-aging supplement that reduces dark melanin production, improves skin luminosity, and diminishes fine lines and wrinkles. Additionally, it is promoted for immune support and may provide benefits for individuals with eczema.

Brand names
LumeniX
02

Targets

TYR (Tyrosinase)

Beyond the preview

Go deeper on LumeniX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LumeniX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call